433 related articles for article (PubMed ID: 15448590)
1. High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response.
Svirshchevskaya EV; Viskova N; Shevchenko M; Alekseeva L; Marchenko A; Benevolensky S; Kurup VP
Med Sci Monit; 2004 Oct; 10(10):BR371-80. PubMed ID: 15448590
[TBL] [Abstract][Full Text] [Related]
2. Molecular and immunological characterization of Asp f 34, a novel major cell wall allergen of Aspergillus fumigatus.
Glaser AG; Kirsch AI; Zeller S; Menz G; Rhyner C; Crameri R
Allergy; 2009 Aug; 64(8):1144-51. PubMed ID: 19416144
[TBL] [Abstract][Full Text] [Related]
3. Antibody binding of deletion mutants of Asp f 2, the major Aspergillus fumigatus allergen.
Tang B; Banerjee B; Greenberger PA; Fink JN; Kelly KJ; Kurup VP
Biochem Biophys Res Commun; 2000 Apr; 270(3):1128-35. PubMed ID: 10772962
[TBL] [Abstract][Full Text] [Related]
4. Identification and expression of an allergen Asp f 13 from Aspergillus fumigatus and epitope mapping using human IgE antibodies and rabbit polyclonal antibodies.
Chow LP; Liu SL; Yu CJ; Liao HK; Tsai JJ; Tang TK
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):423-31. PubMed ID: 10677362
[TBL] [Abstract][Full Text] [Related]
5. A deletion variant of the Aspergillus fumigatus ribotoxin Asp f 1 induces an attenuated airway inflammatory response in a mouse model of sensitization.
Alvarez-García E; Batanero E; García-Fernández R; Villalba M; Gavilanes JG; Martínez-del-Pozo A
J Investig Allergol Clin Immunol; 2010; 20(1):69-75. PubMed ID: 20232776
[TBL] [Abstract][Full Text] [Related]
6. Allergen-related approaches to immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of aspergillus fumigatus allergens.
Banerjee B; Greenberger PA; Fink JN; Kurup VP
Indian J Chest Dis Allied Sci; 2000; 42(4):239-48. PubMed ID: 15597670
[TBL] [Abstract][Full Text] [Related]
8. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
Focke M; Swoboda I; Marth K; Valenta R
Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of allergen-specific antibodies in allergy and specific immunotherapy.
Blaser K; Akdis CA; Faith A
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):243-51; discussion 252. PubMed ID: 11487881
[TBL] [Abstract][Full Text] [Related]
10. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens.
Madan T; Kishore U; Singh M; Strong P; Clark H; Hussain EM; Reid KB; Sarma PU
J Clin Invest; 2001 Feb; 107(4):467-75. PubMed ID: 11181646
[TBL] [Abstract][Full Text] [Related]
11. The role of IgG antibodies in allergy and immunotherapy.
Aalberse R
Allergy; 2011 Jul; 66 Suppl 95():28-30. PubMed ID: 21668848
[TBL] [Abstract][Full Text] [Related]
12. Healthy immune response to allergens: T regulatory cells and more.
Akdis M
Curr Opin Immunol; 2006 Dec; 18(6):738-44. PubMed ID: 17023149
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen.
Marazuela EG; Rodríguez R; Fernández-García H; García MS; Villalba M; Batanero E
Mol Immunol; 2008 Jan; 45(2):438-45. PubMed ID: 17662454
[TBL] [Abstract][Full Text] [Related]
14. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
[TBL] [Abstract][Full Text] [Related]
15. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
[TBL] [Abstract][Full Text] [Related]
16. A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.
Linhart B; Hartl A; Jahn-Schmid B; Verdino P; Keller W; Krauth MT; Valent P; Horak F; Wiedermann U; Thalhamer J; Ebner C; Kraft D; Valenta R
J Allergy Clin Immunol; 2005 May; 115(5):1010-6. PubMed ID: 15867859
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Th2-driven airway inflammation by allergen immunotherapy is independent of B cell and Ig responses in mice.
Shirinbak S; Taher YA; Maazi H; Gras R; van Esch BC; Henricks PA; Samsom JN; Verbeek JS; Lambrecht BN; van Oosterhout AJ; Nawijn MC
J Immunol; 2010 Oct; 185(7):3857-65. PubMed ID: 20802147
[TBL] [Abstract][Full Text] [Related]
18. Determination of T and B Cell Epitopes of Aspergillus fumigatus Ribotoxin and Heat Shock Protein.
Svirshchevskaya EV; Alekseeva LG; Titov VM; Frolova EG; Sapozhnikov AM
Russ J Immunol; 1998 Apr; 3(1):61-68. PubMed ID: 12687087
[TBL] [Abstract][Full Text] [Related]
19. Analysis of IgE and IgG B-cell immunodominant regions of Ole e 1, the main allergen from olive pollen.
González EM; Villalba M; Quiralte J; Batanero E; Roncal F; Albar JP; Rodríguez R
Mol Immunol; 2006 Feb; 43(6):570-8. PubMed ID: 15941589
[TBL] [Abstract][Full Text] [Related]
20. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
